Luteolin Synergistically Enhances Antitumor Activity of Oxaliplatin in Colorectal Carcinoma via AMPK Inhibition.

Jang, Chan Ho; Moon, Nayoung; Lee, Jinkyung; Kwon, Min Jeong; Oh, Jisun; Kim, Jong-Sang

Jang, Chan Ho; Moon, Nayoung; Lee, Jinkyung; Kwon, Min Jeong; Oh, Jisun; Kim, Jong-Sang.

Afiliação

Jang CH; School of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea.
Moon N; School of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea.
Lee J; School of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea.
Kwon MJ; School of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea.
Oh J; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Korea.
Kim JS; School of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea.

Antioxidants (Basel) ; 11(4)2022 Mar 24.

Article em En | MEDLINE | ID: mdl-35453311

Palavras-chave

AMPK inhibition; colorectal cancer; luteolin; oxaliplatin; xenograft tumor

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_colon_rectum_cancers Tipo de estudo: Prognostic_studies Idioma: En Revista: Antioxidants (Basel) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google